0001603978-26-000066
SEC filingOperating losses narrowed 51% to -$622K amid cost reductions following fish rearing exits, though net loss widened to -$1.2M from prior-year profit without non-recurring gains, highlighting ongoing cash burn and funding needs.
AquaBounty Technologies reported a narrower GAAP operating loss of -$621.6 thousand for Q1 2026, improving 50.7% from -$1.3 million in the prior-year quarter. This progress stems from the exit from fish rearing operations, which significantly reduced headcount and ongoing operating costs. With sales of the Indiana Farm in 2024 and Canadian Farms in 2025, the company achieved a leaner structure focused on asset monetization rather than production. General and administrative expenses declined due to lower personnel, audit, legal, insurance, and other costs, while sales and marketing expenses were eliminated post-Canadian Farms sale. These changes explain the operating improvement, positioning the company for minimal operations while pursuing strategic alternatives, though revenue remains absent.
Net income swung to a loss of -$1.2 million from a $401.1 thousand profit last year, with diluted EPS at -$0.26 versus $0.10. The reversal lacks the prior period's non-recurring boosts, underscoring vulnerability to one-time items amid persistent cost pressures. Net cash provided by operating activities improved to -$1.0 million used from -$2.4 million, reflecting moderated burn. Uses of cash from working capital changes arose from decreases in accounts payable and accrued expenses, partly offset by reductions in prepaid expenses and other assets. This easing supports cost discipline but cannot offset the absence of operational cash inflows.
Since inception, cumulative net losses and negative operating cash flows have persisted, with expectations of continuation. This trajectory raises going concern uncertainty, as the company pivots from RAS salmon production to transaction-focused activities with a small core team overseeing IP and assets. Execution risks include dilution, debt covenants, or asset value erosion without positive cash flow visibility. Investors should monitor funding progress and deal announcements amid structural cost reductions.